A study published in Pediatrics shows more than 60 percent of the 1,025 parents surveyed would support age restrictions for tackling in youth football.
The nanoparticle platform for this respiratory syncytial virus study will be applied to vaccine research on flu, HIV, and more. Seattle startup Icosavax will advance related clinical trials.